investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
PP2a protein serine/threonine phosphatase mutations in cancer: functional consequences and clinical relevance
Samuel Aparicio
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Samuel Aparicio
BC Cancer Agency
Vancouver, Canada
Related projects
Melissa Mcconechy
Mutational and Functional Analysis of PPP2R1A in High Risk Endometrial Carcinomas
Corpus uteri
Shyam Sharan
Functional Analysis of Breast Cancer Susceptibility Genes in Mice
Breast
Shoukat Dedhar
Development of therapeutic antibodies targeting carbonic anhydrase IX (CAIX)
Breast
Valerie M Weaver
Collagen Remodeling and Tumor Progression
Breast
Brad Nelson
Toward personalized immunotherapy: identifying tumour-specific factors that dictate the response of spontaneous mammary cancers to T cells
Breast
Xiaojiang Cui
The Role of FOXC1 in Basal-Like Breast Cancer
Breast
Bernard E Weissman
The Tumor Suppressor Role of SMARCA4 in SCCOHT
Ovary
Pathology
Richard A Anderson
PI Signaling Role in Epithelial/Mesenchymal Transition
Breast
Michael Herman Chui
Novel therapeutic targets for CCNE1-amplified high-grade serous ovarian carcinomas
Ovary